Hepatitis A

Aka: Hepatitis A, Hepatitis A Virus

advertisement

II. Epidemiology

  1. Endemic in underdeveloped countries
  2. More common in western United States
  3. Outbreaks
    1. Day-care centers
    2. Residential institutions
  4. Incidence
    1. World: 1.4 Million/year
    2. U.S. (esp west): 60,000/year (only 7700 reported)
      1. Decreased >90% following Hepatitis A Vaccine introduction in 1995

III. Pathophysiology

  1. Picornavirus (enterovirus)
    1. Single stranded RNA genome
    2. Size: 27 nm
    3. Nonenveloped (resistant to bile lysis)
    4. Only replicates in hepatocytes, GI epithelial cells
  2. Hardy agent
    1. Resistant to acids, detergents, freezing Temperatures
    2. Survives in salt water and fresh water, soil, hands
    3. Inactivated by heat >185 F, formalin, Chlorine

IV. Pathophysiology: Timing

  1. Incubation: 15 to 50 days (mean 28 days)
  2. Duration: 2 weeks to 3 months
  3. Contagious status
    1. Infectivity peaks 2 weeks before and 1 week after symptom onset
    2. Stool virus concentration peaks 2 weeks before symptoms
      1. Virus replicates in liver and shed by bilary tract
      2. Stool is highly contagious
      3. Transmission most likely in presymptomatic period
      4. Asymptomatic children may shed virus for months
    3. No longer contagious once significant symptoms occur
      1. Jaundice
      2. Liver transaminase peak

V. Pathophysiology: Transmission

  1. Oral-Fecal transmission
    1. Household or child care centers
    2. Sexual contact
  2. Foodborne Illness epidemic
    1. Infected food handlers
    2. Raw shellfish
    3. Fresh produce (green onions, strawberries)
  3. Waterborne Illness epidemic
  4. Blood exposure can occur but is uncommon

VI. Symptoms

  1. Symptom occurence depends on age
    1. Adults: 70% have symptoms
    2. Children under age 6: 70% do not have symptoms
      1. Usually more mild in young children
  2. Common symptoms (onset 5-7 days before Jaundice)
    1. Fever
    2. Severe Anorexia out of proportion with clinical signs
    3. Nausea and Vomiting
    4. Abdominal Pain
    5. Malaise
    6. Headache
  3. Other less common symptoms
    1. Arthralgias
    2. Myalgias
    3. Diarrhea
    4. Cough
    5. Constipation
    6. Pruritus
    7. Urticaria

VII. Signs: Pre-icteric (starting 5-7 days before Jaundice)

  1. Fever
  2. Enlarged and tender liver (Hepatomegaly)
  3. Splenomegaly
  4. Bradycardia
  5. Posterior cervical adenopathy

VIII. Signs: Icteric phase

  1. Pale, clay colored stool
  2. Dark Urine
  3. Jaundice (Incidence increases with age)
    1. Under age 6: <10%
    2. Adults: Up to 80%

IX. Course

  1. Illness usually lasts 2 months
  2. Not uncommon to miss 1 month of school or work
  3. Usually complete recovery within 6-12 months
  4. No chronic carrier state

X. Labs

  1. Complete Blood Count (CBC)
    1. Leukopenia
  2. Liver Transaminases elevated
    1. Transaminases are higher than in Alcoholic heptitis and similar or lower than toxic or ischemic hepatitis
    2. Alanine Aminotransferase (ALT) elevated (500 - 5000 U/L)
    3. Aspartate Aminotransferase (AST) elevated (500 - 5000 U/L)
      1. Typically lower than the ALT
  3. Liver Function Tests and Cholestasis Labs elevated
    1. Bilirubin elevated (<10 mg/dl)
      1. Increase typically follows the transaminase increase
    2. Alkaline Phosphatase minimally increased

XI. Diagnosis: Hepatitis A Serology

  1. Fecal HAV: present 2-6 weeks after exposure
  2. xHAV IgM
    1. Present 4-12 weeks (up to 6 months) post-exposure
    2. Present 5-10 days before symptom onset
    3. Preferred first-line test (high Test Sensitivity >95%)
      1. Risk of False Positive in asymptomatic patients
  3. xHAV IgG
    1. Present from 4 weeks after exposure
    2. Present life-long and confers immunity

XII. Differential Diagnosis

  1. Acute Hepatitis Causes

XIII. Management

  1. Symptomatic relief
    1. Antiemetics
    2. Avoid Alcohol and other Hepatotoxins
    3. Diet as tolerated otherwise
  2. Rest
    1. Avoid return to work, school until fever and Jaundice resolve

XIV. Management: Post-exposure

  1. Indications
    1. Serologically confirmed case and
    2. Exposure during source patient's incubation period and extending until one week after Jaundice onset
  2. Administer Vaccine or Immunoglobulin within 2 weeks of exposure
  3. Hepatitis A Vaccine (preferred in most cases)
    1. Offer to all outbreak exposures >age 1 years old
    2. Exceptions
      1. Isolated, single case exposures with casual contact (e.g. school, office)
      2. Controlled setting with barrier precautions (e.g. hospital)
  4. Hepatitis A Immunoglobulin (0.02 ml/kg IM) indications
    1. Patient <1 year old
    2. Age over 40 years old
    3. Serious comorbidity
    4. Immunocompromised
    5. Chronic Liver Disease
    6. Severe allergy to Hepatitis A Vaccine
  5. Monitoring
    1. Hepatitis A Virus Antibody testing is optional
  6. References
    1. (2007) MMWR Morb Mortal Wkly Rep 56(41): 1080-4 [PubMed]

XV. Prevention

  1. General Hygiene Measures in endemic areas
    1. Meticulous Hand Washing
    2. Clean surfaces with 1:100 solution household bleach
    3. Careful food preparation
      1. See Prevention of Foodborne Illness
      2. Heat foods to 185 F for 1 minute
      3. Avoid uncooked foods
  2. Hepatitis A Vaccine for high risk potential exposures
    1. Protective for 20 years or more after 2 doses
    2. Recommended as part of Primary Series for child age 1 year
  3. Hepatitis A Immunoglobulin
    1. Preexposure for travel within 1 month
    2. Postexposure for close contacts of known case

XVI. Complications

  1. Most cases follow a benign, self limited course
    1. No increased risk of Cirrhosis and liver cancer
    2. No chronic form of Hepatitis A
  2. Uncommon complications
    1. Relapsing Hepatitis A infection (occurs in up to 15% at up to 6 months after the initial infection)
  3. Rare liver complications
    1. Biliary obstruction
    2. Fulminant Hepatitis (rare)
  4. Rare extra-hepatic complications
    1. Vasculitis
    2. Arthritis
    3. Thrombocytopenia
    4. Acute Pancreatitis
    5. Aplastic or Autoimmune Hemolytic Anemia
    6. Acute Renal Failure
    7. Pericarditis
    8. Guillain-Barre Syndrome
  5. Mortality
    1. Caused 100 U.S. deaths per year prior to routine Hepatitis A Vaccine

XVII. Prognosis: Risk factors for serious complications

  1. Age over 50 years
  2. Underlying liver disease (e.g. Hepatitis B, Hepatitis C)
  3. Pregnancy

XVIII. Resources

  1. CDC Hepatitis A faq
    1. http://www.cdc.gov/hepatitis/hav/havfaq.htm

XIX. References

  1. Jeong (2010) Intervirology 53(1):15-9 [PubMed]
  2. Matheny (2012) Am Fam Physician 86(11): 1027-34 [PubMed]
  3. Yeung (2010) Liver Int 30(1): 5-18 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Hepatitis A." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies (from Trip Database) Open in New Window

Ontology: Hepatitis A (C0019159)

Definition (MEDLINEPLUS)

Hepatitis A is one type of hepatitis - a liver disease - caused by the hepatitis A virus (HAV). The disease is spread primarily through food or water contaminated by stool from an infected person. You can get HAV from

  • Eating food prepared by someone with HAV who did not wash their hands after using the bathroom
  • Having anal/oral sex with someone with HAV
  • Not washing your hands after changing a diaper
  • Drinking contaminated water

HAV can cause swelling of the liver, but it rarely causes lasting damage. You may feel as if you have the flu, or you may have no symptoms at all. It usually gets better on its own after several weeks.

The hepatitis A vaccine can prevent HAV. Healthy habits also make a difference. Wash your hands thoroughly before preparing food, after using the toilet or after changing a diaper. International travelers should be careful about drinking tap water.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Definition (NCI) Acute inflammation of the liver caused by the hepatitis A virus. It is highly contagious and usually contracted through close contact with an infected individual or their feces, contaminated food or water.
Definition (CSP) inflammation of the liver due to microorganism infection.
Definition (MSH) INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
Definition (CSP) hepatitis caused by Hepatovirus (Hepatitis A virus); it can be transmitted through fecal contamination of food or water.
Concepts Disease or Syndrome (T047)
MSH D006506
SnomedCT 154347003, 40468003
LNC LA7442-2
English Hepatitides, Infectious, Hepatitis A, Hepatitis, Infectious, Infectious Hepatitides, Infectious Hepatitis, HEPATITIS A, HEPATITIS INFECTIOUS, INFECT HEPATITIS, HEPATITIS INFECT, hepatitis A infection, hepatitis A infection (diagnosis), hepatitis, A virus, hepatitis A viral infection, Hepatitis A Infection, Hep A, Viral hepatitis A, Hepatitis infectious NOS, Hepatitis A [Disease/Finding], infectious hepatitis (hepatitis A), hepatitis, Hepatitis;infectious, a hepatitis, hep a, hepatitis a, infectious hepatitis a, infectious hepatitis, hepatitis viral, HAV, Infectious hepatitis (disorder), Hepatitis, Hepatitis infectious, Viral hepatitis, type A, Infectious hepatitis, IH - Infectious hepatitis, Viral hepatitis, type A (disorder), epidemic; hepatitis, hepatitis; epidemic, hepatitis; infectious, hepatitis; virus, type, A, infectious; hepatitis, virus; hepatitis, type, A, hepatitis A
French HEPATITE INFECTIEUSE, Hépatite infectieuse SAI, Hép A, HEPATITIE VIRALE A, Hépatite A, Hépatite infectieuse, Hépatite virale A
Portuguese HEPATITE A, HEPATITE INFECCIOSA, Hepatite a vírus A, Hepatite infecciosa NE, Hepatite Viral A, Hepatite infecciosa, Hepatite A, Hepatite Infecciosa
Spanish HEPATITIS A, HEPATITIS INFECCIOSA, Hepatitis infecciosa NEOM, Hepatitis vírica A, hepatitis A, hepatitis infecciosa, hepatitis viral, tipo A (trastorno), hepatitis viral, tipo A, Hepatitis infecciosa, Hepatitis A, Hepatitis Infecciosa
Dutch hepatitis infectiosa NAO, infectieuze hepatitis, virale hepatitis A, epidemisch; hepatitis, hepatitis; epidemisch, hepatitis; infectieus, hepatitis; virus, type, A, infectieus; hepatitis, virus; hepatitis, type, A, hepatitis A, hepatitis infectieus, Hepatitis A, Hepatitis, infectieuze
German Hepatitis infektioes NNB, Hep A, virale Hepatitis A, HEPATITIS INFEKTIOES, infektioese Hepatitis, Hepatitis A, Hepatitis, infektiöse
Italian Epatite infettiva NAS, Epatite virale A, Epatite infettiva, Epatite A
Japanese 感染性肝炎, Ａ型肝炎, 感染性肝炎ＮＯＳ, ｶﾝｾﾝｾｲｶﾝｴﾝNOS, ｶﾝｾﾝｾｲｶﾝｴﾝ, Aｶﾞﾀｶﾝｴﾝ, Ａ型ウイルス性肝炎, Aｶﾞﾀｳｲﾙｽｾｲｶﾝｴﾝ, 肝炎-A型, A型肝炎, 流行性肝炎, 肝炎-流行性, 伝染性肝炎, 肝炎-伝染性
Swedish Hepatit A
Czech hepatitida A, Infekční hepatitis NOS, Hepatitida A, Infekční hepatitis, Virová hepatitida A, infekční hepatitida
Finnish Maksatulehdus A
Russian GEPATIT INFEKTSIONNYI, GEPATIT A, ГЕПАТИТ A, ГЕПАТИТ ИНФЕКЦИОННЫЙ
Croatian HEPATITIS A
Polish Zapalenie wątroby epidemiczne, Żółtaczka zakaźna, Zapalenie wątroby nagminne, Zapalenie wątroby A
Hungarian Hepatitis A, Fertőző májgyulladás, hepatitis infectiosa k.m.n., hepatitis A, hepatitis infectiosa, Viralis hepatitis A
Norwegian Hepatitt A, Epidemisk hepatitt, Infeksiøs hepatitt
Derived from the NIH UMLS (Unified Medical Language System)

Related Topics in Liver

advertisement

2020 Family Practice Notebook, LLC. Terms | Privacy (EHS) | About | Site Map | Blog

Footer Site Logo